Business of Optometry

Top Story

Gemini Therapeutics closes $42.5 million in financing

October 20, 2017

Gemini Therapeutics has completed $42.5 million in Series A financing, according to a company press release.

Co-led by Atlas Venture, Lightstone Ventures and OrbiMed, the financing is to advance multiple programs to the clinical stage, including those focused on genetically defined dry age-related macular degeneration, the release said.

OptiCon to join Vision Expo in 2018

October 20, 2017
Vision Expo and OptiCon have announced a partnership that will bring the company to the expo beginning in 2018 at Vision Expo East in New York. “As we head into…

Blanchard releases new scleral lens design

October 19, 2017
Blanchard Contact Lenses has released a new scleral lens design, called Onefit MED, that simplifies fitting for numerous applications. The Onefit MED has a diameter of…

Court rules Allergan’s Restasis patents invalid, criticizes Native American deal

October 17, 2017
A federal court ruled Monday that Allergan’s patents for Restasis were invalid “based on obviousness,” opening the door to generic competition. Patents…
More Headlines »
CME CE

EDUCATION FOR THE REFERRING EYE CARE SPECIALIST

Diagnosis and Treatment of Myopic Choroidal Neovascularization: Earlier is Better

This activity is supported by an educational grant from Genentech, Inc.

This activity for comprehensive ophthalmologists and optometrists reviews the pathology and symptoms of mCNV; makes…
More »
Video
Meeting News

VIDEO: Private equity to have 'significant impact' on ophthalmology

June 27, 2017
More »
Resource Centers
American Academy of Optometry

American Academy of Optometry

Video
Meeting News

VIDEO: Data analytics important for private ophthalmology practices

June 25, 2017
More »
Advertisement
Advertisement